Common stock, 0.0001 par value 1,500,000,000 shares authorized 17,814,829 and 17,295,582 issued 16,935,754 and 16,552,723 shares outstanding as of june 30, 2026 and december 31, 2025, respectively
2
2
2
2
Additional paid-in capital
2,410,831
2,402,923
2,398,423
2,390,886
Accumulated deficit
-2,562,206
-2,502,980
-2,429,420
-2,348,850
Accumulated other comprehensive loss
-955
-2,351
-4,172
-5,140
Treasury stock - 879,075 and 742,859 shares as of june 30, 2026 and december 31, 2025, respectively
142,236
138,733
138,733
138,733
Total shareholders (deficit)/equity attributable to claritev corporation
-294,564
-241,139
-173,900
-101,835
Non-controlling interests
6,725
6,725
6,725
-
Total shareholders' deficit
-287,839
-234,414
-167,175
-
Total liabilities and shareholders deficit
4,763,857
4,839,299
4,888,458
4,990,301
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.